IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BOSCOLO BIELO, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.024
EU - Europa 842
NA - Nord America 747
SA - Sud America 115
AF - Africa 35
OC - Oceania 3
Totale 2.766
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 713
SG - Singapore 326
CN - Cina 319
DE - Germania 306
IT - Italia 241
HK - Hong Kong 134
BR - Brasile 98
VN - Vietnam 90
SE - Svezia 59
RU - Federazione Russa 54
FR - Francia 49
IN - India 37
NL - Olanda 36
GB - Regno Unito 35
BD - Bangladesh 30
FI - Finlandia 24
TR - Turchia 24
CI - Costa d'Avorio 17
JP - Giappone 12
CA - Canada 11
KR - Corea 11
ID - Indonesia 9
MX - Messico 9
PL - Polonia 8
AT - Austria 7
EG - Egitto 7
PH - Filippine 7
AR - Argentina 5
EC - Ecuador 4
IQ - Iraq 4
TH - Thailandia 4
ZA - Sudafrica 4
AU - Australia 3
CH - Svizzera 3
ES - Italia 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
TT - Trinidad e Tobago 3
BE - Belgio 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
LT - Lituania 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
UA - Ucraina 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MA - Marocco 1
NI - Nicaragua 1
RS - Serbia 1
SA - Arabia Saudita 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 2.766
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 272
Ashburn 153
Dallas 142
Singapore 133
Hong Kong 108
Hefei 91
Milan 75
San Jose 74
Los Angeles 48
Beijing 35
Council Bluffs 31
Ho Chi Minh City 30
New York 24
Boardman 23
Hanoi 21
Santa Clara 21
Bengaluru 20
Lauterbourg 20
Rome 20
Istanbul 19
Abidjan 17
Moscow 15
Helsinki 13
Munich 13
São Paulo 13
Shanghai 12
Naples 11
Tokyo 11
Buffalo 10
Seoul 9
Cangzhou 8
Düsseldorf 8
Atlanta 7
Columbus 7
Oklahoma City 7
Boston 6
Guangzhou 6
Lappeenranta 6
London 6
Palermo 6
Cairo 5
Chicago 5
Da Nang 5
Manila 5
Paris 5
Rho 5
Seattle 5
Turku 5
Vienna 5
Ankara 4
Barnet 4
Chennai 4
Haiphong 4
Hyderabad 4
Jakarta 4
Manchester 4
Montreal 4
Rio de Janeiro 4
Turin 4
Verona 4
Wuhan 4
Amsterdam 3
Bangkok 3
Brescia 3
Brooklyn 3
Cologne 3
Cusano Milanino 3
Des Moines 3
Genoa 3
Johannesburg 3
Marseille 3
Mexico City 3
Mumbai 3
Nuremberg 3
Poplar 3
Quanzhou 3
Roubaix 3
San Antonio 3
Warsaw 3
Wroclaw 3
Zurich 3
Alcamo 2
Anyang 2
Barcelona 2
Baronissi 2
Bauru 2
Berlin 2
Bexley 2
Biên Hòa 2
Bologna 2
Bron 2
Brussels 2
Bucharest 2
Caivano 2
Can Tho 2
Cascavel 2
Changchun 2
Chieti 2
Dublin 2
Fortaleza 2
Totale 1.742
Salva come PNG Salva come JPEG
Nome #
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents 245
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer 223
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact 207
Future potential targets of antibody-drug conjugates in breast cancer 202
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates 166
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations 163
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 144
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments 143
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial 143
Molecular tumor board in patients with metastatic breast cancer 142
The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis 129
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study 126
Germline BRCA pathogenic variants in patients with ovarian cancer and post-poly (ADP-ribose) polymerase inhibitor myeloid neoplasms 122
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit 117
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience 109
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis 103
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology 99
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer 95
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers 83
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study 75
Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignancies 8
null 6
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study 5
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial 3
A machine learning assay to predict disease recurrence in hormone receptor-positive breast cancer 1
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial 1
Evolving roles of liquid biopsy in precision medicine for colorectal cancer: from single-gene analysis to broad genomic profiling 1
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice 1
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial 1
Treatment of Oligometastatic BRAFV600E Mutant Colorectal Cancer: Learning From a Clinical Case 1
HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study 1
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer 1
Molecular tumour board in gastrointestinal cancers 1
Totale 2.867
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024298 5 5 13 11 18 20 35 23 23 34 54 57
2024/2025625 49 44 50 39 18 10 9 62 51 74 77 142
2025/20261.944 223 252 299 229 108 76 226 92 137 133 169 0
Totale 2.867